FLGT
Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (FLGT) has 17 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 28, 2026.
Insiders have net sold $106K over the trailing 6 months.
- Industry:Medical - Diagnostics & Research
- CEO:Ming Hsieh
- Employees:1,313
- HQ:El Monte, CA, US
- IPO:2016-09-29
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$106K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$574.0M
latest known value
Related companies
Fulgent Genetics, Inc. is in the Healthcare sector.